Literature DB >> 16809770

5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.

Keith R Laderoute1, Khalid Amin, Joy M Calaoagan, Merrill Knapp, Theresamai Le, Juan Orduna, Marc Foretz, Benoit Viollet.   

Abstract

Low oxygen gradients (hypoxia and anoxia) are important determinants of pathological conditions under which the tissue blood supply is deficient or defective, such as in solid tumors. We have been investigating the relationship between the activation of hypoxia-inducible factor 1 (HIF-1), the primary transcriptional regulator of the mammalian response to hypoxia, and 5'-AMP-activated protein kinase (AMPK), another regulatory system important for controlling cellular energy metabolism. In the present study, we used mouse embryo fibroblasts nullizygous for HIF-1alpha or AMPK expression to show that AMPK is rapidly activated in vitro by both physiological and pathophysiological low-oxygen conditions, independently of HIF-1 activity. These findings imply that HIF-1 and AMPK are components of a concerted cellular response to maintain energy homeostasis in low-oxygen or ischemic-tissue microenvironments. Finally, we used transformed derivatives of wild-type and HIF-1alpha- or AMPKalpha-null mouse embryo fibroblasts to determine whether AMPK is activated in vivo. We obtained evidence that AMPK is activated in authentic hypoxic tumor microenvironments and that this activity overlaps with regions of hypoxia detected by a chemical probe. We also showed that AMPK is important for the growth of this tumor model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809770      PMCID: PMC1592699          DOI: 10.1128/MCB.00166-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.

Authors:  J A Raleigh; S C Chou; D P Calkins-Adams; C A Ballenger; D B Novotny; M A Varia
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

2.  Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides.

Authors:  C Beauloye; A S Marsin; L Bertrand; U Krause; D G Hardie; J L Vanoverschelde; L Hue
Journal:  FEBS Lett       Date:  2001-09-21       Impact factor: 4.124

3.  The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.

Authors:  S Shan; A C Lockhart; W Y Saito; A M Knapp; K R Laderoute; M W Dewhirst
Journal:  Clin Cancer Res       Date:  2001-08       Impact factor: 12.531

4.  The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent.

Authors:  Keith R Laderoute; Joy M Calaoagan; Cindy Gustafson-Brown; A Merrill Knapp; Guo-Chun Li; Holly L Mendonca; Heather E Ryan; Zhaohui Wang; Randall S Johnson
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia.

Authors:  A S Marsin; L Bertrand; M H Rider; J Deprez; C Beauloye; M F Vincent; G Van den Berghe; D Carling; L Hue
Journal:  Curr Biol       Date:  2000-10-19       Impact factor: 10.834

6.  Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation.

Authors:  Kazuyoshi Kato; Tsutomu Ogura; Atsuhiro Kishimoto; Yuji Minegishi; Nobuyuki Nakajima; Masaru Miyazaki; Hiroyasu Esumi
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

Review 7.  Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase.

Authors:  D G Hardie; D A Pan
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

8.  Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5'-AMP-activated protein kinase-dependent manner.

Authors:  Hiroyasu Esumi; Kunihiko Izuishi; Kazuyoshi Kato; Koichi Hashimoto; Yukiko Kurashima; Atsuhiro Kishimoto; Tsutomu Ogura; Takayuki Ozawa
Journal:  J Biol Chem       Date:  2002-06-28       Impact factor: 5.157

9.  AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma.

Authors:  Kathryn M Neurath; Martin P Keough; Tom Mikkelsen; Kevin P Claffey
Journal:  Glia       Date:  2006-05       Impact factor: 7.452

10.  The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase.

Authors:  Anne-Sophie Marsin; Caroline Bouzin; Luc Bertrand; Louis Hue
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

View more
  234 in total

1.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress.

Authors:  Sang-Min Jeon; Navdeep S Chandel; Nissim Hay
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962

2.  Autoactivation of transforming growth factor beta-activated kinase 1 is a sequential bimolecular process.

Authors:  Roland Scholz; Corinne L Sidler; Ramon F Thali; Nicolas Winssinger; Peter C F Cheung; Dietbert Neumann
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

3.  Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer.

Authors:  Peter J Mazzone; Xiao-Feng Wang; Yaomin Xu; Tarek Mekhail; Mary C Beukemann; Jie Na; Jonathan W Kemling; Kenneth S Suslick; Madhu Sasidhar
Journal:  J Thorac Oncol       Date:  2012-01       Impact factor: 15.609

4.  Ginsenoside Rg1 inhibits autophagy in H9c2 cardiomyocytes exposed to hypoxia/reoxygenation.

Authors:  Zi-Long Zhang; Yan Fan; Mei-Lin Liu
Journal:  Mol Cell Biochem       Date:  2012-02-21       Impact factor: 3.396

5.  The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.

Authors:  T L Ng; G Leprivier; M D Robertson; C Chow; M J Martin; K R Laderoute; E Davicioni; T J Triche; P H B Sorensen
Journal:  Cell Death Differ       Date:  2011-09-23       Impact factor: 15.828

6.  Cancer metabolism: Tumour friend or foe.

Authors:  Robert U Svensson; Reuben J Shaw
Journal:  Nature       Date:  2012-05-31       Impact factor: 49.962

7.  Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.

Authors:  Chiara Bardella; Martina Olivero; Annalisa Lorenzato; Massimo Geuna; Julie Adam; Linda O'Flaherty; Pierre Rustin; Ian Tomlinson; Patrick J Pollard; Maria Flavia Di Renzo
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

8.  Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation.

Authors:  David Bungard; Benjamin J Fuerth; Ping-Yao Zeng; Brandon Faubert; Nancy L Maas; Benoit Viollet; David Carling; Craig B Thompson; Russell G Jones; Shelley L Berger
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

Review 9.  Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.

Authors:  Biplab Dasgupta; Rishi Raj Chhipa
Journal:  Trends Pharmacol Sci       Date:  2015-12-20       Impact factor: 14.819

10.  Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.

Authors:  Maral Jamshidi; Marjanka K Schmidt; Thilo Dörk; Montserrat Garcia-Closas; Tuomas Heikkinen; Sten Cornelissen; Alexandra J van den Broek; Peter Schürmann; Andreas Meyer; Tjoung-Won Park-Simon; Jonine Figueroa; Mark Sherman; Jolanta Lissowska; Garrett Teoh Hor Keong; Astrid Irwanto; Marko Laakso; Sampsa Hautaniemi; Kristiina Aittomäki; Carl Blomqvist; Jianjun Liu; Heli Nevanlinna
Journal:  Int J Cancer       Date:  2012-10-25       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.